| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.43T | 4.43T | 4.31T | 4.11T | 3.25T |
| Gross Profit | 1.58T | 1.60T | 1.54T | 1.50T | 1.23T |
| EBITDA | 835.42B | 810.06B | 775.59B | 719.59B | 628.59B |
| Net Income | 327.26B | 284.99B | 327.93B | 298.93B | 161.56B |
Balance Sheet | |||||
| Total Assets | 5.75T | 5.72T | 5.43T | 4.96T | 4.57T |
| Cash, Cash Equivalents and Short-Term Investments | 713.81B | 718.16B | 724.60B | 518.90B | 787.54B |
| Total Debt | 1.10T | 727.72B | 830.16B | 767.17B | 811.14B |
| Total Liabilities | 2.03T | 1.94T | 2.02T | 1.95T | 1.90T |
| Stockholders Equity | 3.66T | 3.73T | 3.35T | 2.97T | 2.63T |
Cash Flow | |||||
| Free Cash Flow | 409.35B | 249.55B | 318.50B | 13.76B | 96.55B |
| Operating Cash Flow | 660.44B | 548.84B | 661.43B | 268.48B | 281.54B |
| Investing Cash Flow | -224.97B | -255.06B | -297.72B | -338.00B | 131.70B |
| Financing Cash Flow | -429.90B | -343.26B | -183.66B | -364.11B | -379.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥702.42B | 11.68 | 15.27% | 2.93% | 2.81% | 2.78% | |
75 Outperform | ¥577.78B | 13.50 | 8.26% | 2.62% | 1.44% | -0.92% | |
72 Outperform | ¥4.76T | 15.43 | 6.59% | 3.07% | 0.24% | -23.93% | |
70 Outperform | ¥676.54B | 14.52 | 4.89% | 2.59% | -0.26% | 129.15% | |
69 Neutral | ¥1.18T | 11.79 | 9.11% | 1.60% | 10.53% | -2.52% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |